Diagnosis, natural history, and management of Charcot–Marie–Tooth disease

D Pareyson, C Marchesi - The Lancet Neurology, 2009 - thelancet.com
Summary Charcot–Marie–Tooth disease is the most common inherited neuromuscular
disorder. There have been substantial advances in elucidating the molecular bases of this …

Chemical composition of selected insect meals and their effect on apparent total tract digestibility, fecal metabolites, and microbiota of adult cats fed insect-based …

LM Reilly, Y Hu, PC Von Schaumburg… - Journal of animal …, 2022 - academic.oup.com
Insect meals are novel and potentially sustainable protein sources. The objectives of this
study were to determine the chemical composition and standardized amino acid digestibility …

CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis

V Fridman, B Bundy, MM Reilly, D Pareyson… - Journal of Neurology …, 2015 - jnnp.bmj.com
Background The international Inherited Neuropathy Consortium (INC) was created with the
goal of obtaining much needed natural history data for patients with Charcot-Marie-Tooth …

Charcot‐Marie‐Tooth disease subtypes and genetic testing strategies

ASD Saporta, SL Sottile, LJ Miller… - Annals of …, 2011 - Wiley Online Library
Abstract Objective Charcot‐Marie‐Tooth disease (CMT) affects 1 in 2,500 people and is
caused by mutations in more than 30 genes. Identifying the genetic cause of CMT is often …

Reliability of the CMT neuropathy score (second version) in Charcot‐Marie‐Tooth disease

SM Murphy, DN Herrmann… - Journal of the …, 2011 - Wiley Online Library
The Charcot‐Marie‐Tooth neuropathy score (CMTNS) is a reliable and valid composite
score comprising symptoms, signs, and neurophysiological tests, which has been used in …

[HTML][HTML] Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy

D Adams, OB Suhr, PJ Dyck, WJ Litchy, RG Leahy… - BMC neurology, 2017 - Springer
Background Patisiran is an investigational RNA interference (RNAi) therapeutic in
development for the treatment of hereditary ATTR (hATTR) amyloidosis, a progressive …

[HTML][HTML] Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

D Pareyson, MM Reilly, A Schenone… - The Lancet …, 2011 - thelancet.com
Background Ascorbic acid reduced the severity of neuropathy in transgenic mice
overexpressing peripheral myelin protein 22 (PMP22), a model of Charcot–Marie–Tooth …

[HTML][HTML] PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies

BW van Paassen, AJ van der Kooi… - Orphanet journal of rare …, 2014 - Springer
Abstract PMP22 related neuropathies comprise (1) PMP22 duplications leading to Charcot-
Marie-Tooth disease type 1A (CMT1A),(2) PMP22 deletions, leading to Hereditary …

[HTML][HTML] Emerging therapies for Charcot-Marie-Tooth inherited neuropathies

M Stavrou, I Sargiannidou, E Georgiou… - International Journal of …, 2021 - mdpi.com
Inherited neuropathies known as Charcot-Marie-Tooth (CMT) disease are genetically
heterogeneous disorders affecting the peripheral nerves, causing significant and slowly …

Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1

V Fridman, S Suriyanarayanan, P Novak, W David… - Neurology, 2019 - AAN Enterprises
Objective To evaluate the safety and efficacy of l-serine in humans with hereditary sensory
autonomic neuropathy type I (HSAN1). Methods In this randomized, placebo-controlled …